Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2010

01-06-2010 | Preclinical study

Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence

Published in: Breast Cancer Research and Treatment | Issue 2/2010

Login to get access

Abstract

Adult human mesenchymal stem cells (hMSCs) have been shown to home to sites of breast cancer and integrate into the tumor stroma. We demonstrate here the effect of hMSCs on primary breast tumor growth and the progression of these tumors to hormone independence. Co-injection of bone marrow-derived hMSCs enhances primary tumor growth of the estrogen receptor-positive, hormone-dependent breast carcinoma cell line MCF-7 in the presence or absence of estrogen in SCID/beige mice. We also show hormone-independent growth of MCF-7 cells when co-injected with hMSCs. These effects were found in conjunction with increased immunohistochemical staining of the progesterone receptor in the MCF-7/hMSC tumors as compared to MCF-7 control tumors. This increase in PgR expression indicates a link between MCF-7 cells and MSCs through ER-mediated signaling. Taken together, our data reveal the relationship between tumor microenvironment and tumor growth and the progression to hormone independence. This tumor stroma-cell interaction may provide a novel target for the treatment of estrogen receptor-positive, hormone-independent, and endocrine-resistant breast carcinoma.
Appendix
Available only for authorised users
Literature
1.
go back to reference Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71–74CrossRefPubMed Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71–74CrossRefPubMed
2.
go back to reference Horwitz EM, Prockop DJ, Fitzpatrick LA et al (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309–313CrossRefPubMed Horwitz EM, Prockop DJ, Fitzpatrick LA et al (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309–313CrossRefPubMed
3.
go back to reference Fox JM, Chamberlain G, Ashton BA et al (2007) Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 137:491–502CrossRefPubMed Fox JM, Chamberlain G, Ashton BA et al (2007) Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 137:491–502CrossRefPubMed
4.
go back to reference Studeny M, Marini FC, Dembinski JL et al (2004) Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96:1593–1603PubMedCrossRef Studeny M, Marini FC, Dembinski JL et al (2004) Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96:1593–1603PubMedCrossRef
6.
go back to reference Hasebe T, Sasaki S, Sugitoh M et al (2001) Highly proliferative intratumoral fibroblasts and a high proliferative microvessel index are significant predictors of tumor metastasis in T3 ulcerative-type colorectal cancer. Hum Pathol 32:401–409CrossRefPubMed Hasebe T, Sasaki S, Sugitoh M et al (2001) Highly proliferative intratumoral fibroblasts and a high proliferative microvessel index are significant predictors of tumor metastasis in T3 ulcerative-type colorectal cancer. Hum Pathol 32:401–409CrossRefPubMed
7.
go back to reference Kuniyasu H, Abbruzzese JL, Cleary KR et al (2001) Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma. Int J Oncol 19:681–685PubMed Kuniyasu H, Abbruzzese JL, Cleary KR et al (2001) Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma. Int J Oncol 19:681–685PubMed
8.
go back to reference Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650–1659PubMed Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650–1659PubMed
9.
go back to reference Studeny M, Marini FC, Champlin RE et al (2002) Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62:3603–3608PubMed Studeny M, Marini FC, Champlin RE et al (2002) Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62:3603–3608PubMed
10.
go back to reference Hall B, Andreeff M, Marini F (2007) The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol 180:263–283CrossRefPubMed Hall B, Andreeff M, Marini F (2007) The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol 180:263–283CrossRefPubMed
11.
go back to reference Djouad F, Bony C, Apparailly F et al (2006) Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells. Transplantation 82:1060–1066CrossRefPubMed Djouad F, Bony C, Apparailly F et al (2006) Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells. Transplantation 82:1060–1066CrossRefPubMed
12.
go back to reference Karnoub AE, Dash AB, Vo AP et al (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557–563CrossRefPubMed Karnoub AE, Dash AB, Vo AP et al (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557–563CrossRefPubMed
13.
go back to reference Sekiya I, Larson BL, Smith JR et al (2002) Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20:530–541CrossRefPubMed Sekiya I, Larson BL, Smith JR et al (2002) Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20:530–541CrossRefPubMed
14.
go back to reference Petz LN, Ziegler YS, Schultz JR et al (2004) Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site. Mol Endocrinol 18:521–532CrossRefPubMed Petz LN, Ziegler YS, Schultz JR et al (2004) Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site. Mol Endocrinol 18:521–532CrossRefPubMed
15.
go back to reference Salvo VA, Boue SM, Fonseca JP et al (2006) Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. Clin Cancer Res 12:7159–7164CrossRefPubMed Salvo VA, Boue SM, Fonseca JP et al (2006) Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. Clin Cancer Res 12:7159–7164CrossRefPubMed
16.
go back to reference Team RDC (ed) (2008) A language and environment for statistical computing. Foundation for statistical computing, Vienna, Austria Team RDC (ed) (2008) A language and environment for statistical computing. Foundation for statistical computing, Vienna, Austria
17.
go back to reference Pinheiro J, Bates DM (2000) Mixed-effects models in S and S-PLUS. Springer Verlag, New YorkCrossRef Pinheiro J, Bates DM (2000) Mixed-effects models in S and S-PLUS. Springer Verlag, New YorkCrossRef
18.
go back to reference Kagiwada H, Yashiki T, Ohshima A et al (2008) Human mesenchymal stem cells as a stable source of VEGF-producing cells. J Tissue Eng Regen Med 2:184–189CrossRefPubMed Kagiwada H, Yashiki T, Ohshima A et al (2008) Human mesenchymal stem cells as a stable source of VEGF-producing cells. J Tissue Eng Regen Med 2:184–189CrossRefPubMed
19.
go back to reference Hill RP (2006) Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 66:1891–1895 (discussion 1890)CrossRefPubMed Hill RP (2006) Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 66:1891–1895 (discussion 1890)CrossRefPubMed
20.
go back to reference Li Z, Carrier L, Belame A et al. (2008) Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis. Breast Cancer Res Treat. doi:10.1007/s10549-008-0216-x Li Z, Carrier L, Belame A et al. (2008) Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis. Breast Cancer Res Treat. doi:10.​1007/​s10549-008-0216-x
21.
go back to reference White AC, Levy JA, McGrath CM (1982) Site-selective growth of a hormone-responsive human breast carcinoma in athymic mice. Cancer Res 42:906–912PubMed White AC, Levy JA, McGrath CM (1982) Site-selective growth of a hormone-responsive human breast carcinoma in athymic mice. Cancer Res 42:906–912PubMed
22.
go back to reference Levy JA, White AC, McGrath CM (1982) Growth and histology of a human mammary-carcinoma cell line at different sites in the athymic mouse. Br J Cancer 45:375–383PubMed Levy JA, White AC, McGrath CM (1982) Growth and histology of a human mammary-carcinoma cell line at different sites in the athymic mouse. Br J Cancer 45:375–383PubMed
23.
go back to reference Fiedler J, Leucht F, Waltenberger J et al (2005) VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 334:561–568CrossRefPubMed Fiedler J, Leucht F, Waltenberger J et al (2005) VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 334:561–568CrossRefPubMed
24.
go back to reference Fierro FA, Sierralta WD, Epunan MJ et al (2004) Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination. Clin Exp Metastasis 21:313–319CrossRefPubMed Fierro FA, Sierralta WD, Epunan MJ et al (2004) Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination. Clin Exp Metastasis 21:313–319CrossRefPubMed
25.
go back to reference Hombauer H, Minguell JJ (2000) Selective interactions between epithelial tumour cells and bone marrow mesenchymal stem cells. Br J Cancer 82:1290–1296CrossRefPubMed Hombauer H, Minguell JJ (2000) Selective interactions between epithelial tumour cells and bone marrow mesenchymal stem cells. Br J Cancer 82:1290–1296CrossRefPubMed
26.
go back to reference Muller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56CrossRefPubMed Muller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56CrossRefPubMed
27.
go back to reference Sasser AK, Mundy BL, Smith KM et al (2007) Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Lett 254:255–264CrossRefPubMed Sasser AK, Mundy BL, Smith KM et al (2007) Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Lett 254:255–264CrossRefPubMed
28.
go back to reference Yang SH, Wu CC, Shih TT et al (2008) In vitro study on interaction between human nucleus pulposus cells and mesenchymal stem cells through paracrine stimulation. Spine 33:1951–1957CrossRefPubMed Yang SH, Wu CC, Shih TT et al (2008) In vitro study on interaction between human nucleus pulposus cells and mesenchymal stem cells through paracrine stimulation. Spine 33:1951–1957CrossRefPubMed
29.
go back to reference Nicola MH, Bizon R, Machado JJ et al (2003) Breast cancer micrometastases: different interactions of carcinoma cells with normal and cancer patients’ bone marrow stromata. Clin Exp Metastasis 20:471–479CrossRefPubMed Nicola MH, Bizon R, Machado JJ et al (2003) Breast cancer micrometastases: different interactions of carcinoma cells with normal and cancer patients’ bone marrow stromata. Clin Exp Metastasis 20:471–479CrossRefPubMed
Metadata
Title
Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence
Publication date
01-06-2010
Published in
Breast Cancer Research and Treatment / Issue 2/2010
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-009-0458-2

Other articles of this Issue 2/2010

Breast Cancer Research and Treatment 2/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine